Last 12 months
Inside the activity.
2 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 1 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 04, 2023 Filed Dec 6, 2023 21:39 UTC |
Cormorant Asset Management, LP10% owner
Chen Bihua10% owner
|
PurchaseCommon Stock | 28,090 | $22.80 | $640,452.00 |
DisclosureSEC source: 0000929638-23-003383 · form4.xml · nonDerivative · entry 5 Cormorant Asset Management, LP · CIK 0001583977 · 10% owner Chen Bihua · CIK 0001599214 · 10% owner Cormorant Global Healthcare Master Fund, LP · CIK 0001618442 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 5,028,386 F6 · price: Represents the weighted average sale price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $22.30 to $23.29 per share. F19 · price: The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of the shares reported herein were purchased by the Master Fund. F1 · ownership.nature: Cormorant Asset Management, LP ("Cormorant") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the "Master Fund"). Cormorant Global Healthcare GP, LLC ("GP LLC") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose. Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 21:39 UTC |
Cormorant Asset Management, LP10% owner
Chen Bihua10% owner
|
PurchaseCommon Stock | 79,805 | $21.87 | $1,745,335.35 |
DisclosureSEC source: 0000929638-23-003383 · form4.xml · nonDerivative · entry 4 Cormorant Asset Management, LP · CIK 0001583977 · 10% owner Chen Bihua · CIK 0001599214 · 10% owner Cormorant Global Healthcare Master Fund, LP · CIK 0001618442 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 5,000,296 F5 · price: Represents the weighted average sale price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $21.30 to $22.29 per share. F19 · price: The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of the shares reported herein were purchased by the Master Fund. F1 · ownership.nature: Cormorant Asset Management, LP ("Cormorant") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the "Master Fund"). Cormorant Global Healthcare GP, LLC ("GP LLC") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose. Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 21:39 UTC |
Cormorant Asset Management, LP10% owner
Chen Bihua10% owner
|
PurchaseCommon Stock | 122,625 | $20.62 | $2,528,527.50 |
DisclosureSEC source: 0000929638-23-003383 · form4.xml · nonDerivative · entry 3 Cormorant Asset Management, LP · CIK 0001583977 · 10% owner Chen Bihua · CIK 0001599214 · 10% owner Cormorant Global Healthcare Master Fund, LP · CIK 0001618442 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 4,920,491 F4 · price: Represents the weighted average sale price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $20.30 to $21.29 per share. F19 · price: The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of the shares reported herein were purchased by the Master Fund. F1 · ownership.nature: Cormorant Asset Management, LP ("Cormorant") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the "Master Fund"). Cormorant Global Healthcare GP, LLC ("GP LLC") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose. Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 21:39 UTC |
Cormorant Asset Management, LP10% owner
Chen Bihua10% owner
|
PurchaseCommon Stock | 945,664 | $19.88 | $18,799,800.32 |
DisclosureSEC source: 0000929638-23-003383 · form4.xml · nonDerivative · entry 2 Cormorant Asset Management, LP · CIK 0001583977 · 10% owner Chen Bihua · CIK 0001599214 · 10% owner Cormorant Global Healthcare Master Fund, LP · CIK 0001618442 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 4,797,866 F3 · price: Represents the weighted average sale price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $19.30 to $20.30 per share. F19 · price: The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of the shares reported herein were purchased by the Master Fund. F1 · ownership.nature: Cormorant Asset Management, LP ("Cormorant") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the "Master Fund"). Cormorant Global Healthcare GP, LLC ("GP LLC") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose. Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 21:39 UTC |
Cormorant Asset Management, LP10% owner
Chen Bihua10% owner
|
PurchaseCommon Stock | 321,259 | $18.80 | $6,039,669.20 |
DisclosureSEC source: 0000929638-23-003383 · form4.xml · nonDerivative · entry 1 Cormorant Asset Management, LP · CIK 0001583977 · 10% owner Chen Bihua · CIK 0001599214 · 10% owner Cormorant Global Healthcare Master Fund, LP · CIK 0001618442 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 3,852,202 F2 · price: Represents the weighted average sale price of Common Stock (the "shares") purchased in a series of open market transactions on the transaction date at prices ranging from $18.30 to $19.30 per share. F19 · price: The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of the shares reported herein were purchased by the Master Fund. F1 · ownership.nature: Cormorant Asset Management, LP ("Cormorant") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the "Master Fund"). Cormorant Global Healthcare GP, LLC ("GP LLC") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose. Read SEC document |
| December 04, 2023 Filed Dec 11, 2023 21:15 UTC Amendment |
Pine Michael CraigChief Corp Dev.&Strat. Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $12.62 | $0.00 |
DisclosureSEC source: 0001562180-23-008273 · primarydocument.xml · derivative · entry 4 Pine Michael Craig · CIK 0001904458 · Chief Corp Dev.&Strat. Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 45,000 shares Expires 2032-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at January 10th, 2023 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| December 04, 2023 Filed Dec 11, 2023 21:15 UTC Amendment |
Pine Michael CraigChief Corp Dev.&Strat. Officer
|
SaleCommon Stock | 1,000 | $20.79 | $20,790.00 |
DisclosureSEC source: 0001562180-23-008273 · primarydocument.xml · nonDerivative · entry 3 Pine Michael Craig · CIK 0001904458 · Chief Corp Dev.&Strat. Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,343 F2 · shares: This owned share transaction was inadvertently left off of the original Form 4 filing on December 6, 2023. Read SEC document |
| December 04, 2023 Filed Dec 11, 2023 21:15 UTC Amendment |
Pine Michael CraigChief Corp Dev.&Strat. Officer
|
SaleCommon Stock | 45,000 | $22.00 | $990,000.00 |
DisclosureSEC source: 0001562180-23-008273 · primarydocument.xml · nonDerivative · entry 2 Pine Michael Craig · CIK 0001904458 · Chief Corp Dev.&Strat. Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,343 Read SEC document |
| December 04, 2023 Filed Dec 11, 2023 21:15 UTC Amendment |
Pine Michael CraigChief Corp Dev.&Strat. Officer
|
Exercise / conversionCommon Stock | 45,000 | $12.62 | $567,900.00 |
DisclosureSEC source: 0001562180-23-008273 · primarydocument.xml · nonDerivative · entry 1 Pine Michael Craig · CIK 0001904458 · Chief Corp Dev.&Strat. Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Includes 2,159 shares acquired on January 31, 2023 and 2,184 shares acquired on July 31,2023 pursuant to EyePoint's 2019 Employee Stock Purchase Plan. Read SEC document |
| October 16, 2023 Filed Oct 17, 2023 20:47 UTC |
Elston GeorgeChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $8.23 | $0.00 |
DisclosureSEC source: 0001562180-23-007325 · primarydocument.xml · derivative · entry 1 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2033-10-15 F1 · derivative.exercise_date: The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remainig thirty-six months Read SEC document |
| October 16, 2023 Filed Oct 17, 2023 20:49 UTC |
Duty StuartDirector
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $8.23 | $0.00 |
DisclosureSEC source: 0001562180-23-007327 · primarydocument.xml · derivative · entry 1 Duty Stuart · CIK 0001970274 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2033-10-15 F1 · derivative.exercise_date: The option becomes exercisable in three ratable annual installments beginning on October 16, 2024. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 19:10 UTC Amendment |
EW Healthcare Partners, L.P.10% owner · See footnotes 1 and 3
EW Healthcare Partners-A, L.P.10% owner · See footnotes 1 and 3
Essex Woodlands Fund IX-GP, L.P.10% owner
Essex Woodlands IX, LLC10% owner
|
SaleCommon Stock, $0.001 par value | 20,000 | $9.90 | $197,982.00 |
DisclosureSEC source: 0000899243-23-018661 · doc4a.xml · nonDerivative · entry 1 EW Healthcare Partners, L.P. · CIK 0001612343 · 10% owner · See footnotes 1 and 3 EW Healthcare Partners-A, L.P. · CIK 0001736240 · 10% owner · See footnotes 1 and 3 Essex Woodlands Fund IX-GP, L.P. · CIK 0001652285 · 10% owner Essex Woodlands IX, LLC · CIK 0001652286 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 3,490,921 F2 · price: Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date within a one dollar range. Actual prices ranged from $9.73 to $10.11. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · ownership.nature: The share total shown above is the aggregate amount of shares of Common Stock sold by EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A") on the date set forth above. EWHP sold 19,226 shares of the amount shown above, and EWHP-A sold 774 shares of the amount shown above. EWHP now holds a total of 3,355,921 shares of Common Stock of the Issuer and EWHP-A now holds a total of 135,000 shares of Common Stock of the Issuer. F3 · ownership.nature: Essex Woodlands Fund IX-GP, L.P. (the "EW Fund IX GP"), is the general partner of each of EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A" and together with EWHP, the "EWHP Funds"). Essex Woodlands IX, LLC (the "General Partner") is the general partner of EW Fund IX GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EWHP Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Scott Barry, Ron Eastman, Petri Vainio and Steve Wiggins (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Fund IX GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 17:14 UTC |
EW Healthcare Partners, L.P.10% owner · See footnotes 1 and 3
EW Healthcare Partners-A, L.P.10% owner · See footnotes 1 and 3
Essex Woodlands Fund IX-GP, L.P.10% owner
Essex Woodlands IX, LLC10% owner
|
SaleCommon Stock, $0.001 par value | 20,000 | $9.90 | $197,982.00 |
DisclosureSEC source: 0000899243-23-018658 · doc4.xml · nonDerivative · entry 1 EW Healthcare Partners, L.P. · CIK 0001612343 · 10% owner · See footnotes 1 and 3 EW Healthcare Partners-A, L.P. · CIK 0001736240 · 10% owner · See footnotes 1 and 3 Essex Woodlands Fund IX-GP, L.P. · CIK 0001652285 · 10% owner Essex Woodlands IX, LLC · CIK 0001652286 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 3,490,921 F2 · price: Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date within a one dollar range. Actual prices ranged from $9.73 to $10.11. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · ownership.nature: The share total shown above is the aggregate amount of shares of Common Stock sold by EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A") on the date set forth above. EWHP sold 19,226 shares of the amount shown above, and EWHP-A sold 774 shares of the amount shown above. EWHP now holds a total of 3,355,921 shares of Common Stock of the Issuer and EWHP-A now holds a total of 135,000 shares of Common Stock of the Issuer. F3 · ownership.nature: Essex Woodlands Fund IX-GP, L.P. (the "EW Fund IX GP"), is the general partner of each of EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A" and together with EWHP, the "EWHP Funds"). Essex Woodlands IX, LLC (the "General Partner") is the general partner of EW Fund IX GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EWHP Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Scott Barry, Ron Eastman, Petri Vainio and Steve Wiggins (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Fund IX GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| August 31, 2023 Filed Sep 1, 2023 16:51 UTC |
EW Healthcare Partners, L.P.10% owner · See footnotes 1 and 6
EW Healthcare Partners-A, L.P.10% owner · See footnotes 1 and 6
Essex Woodlands Fund IX-GP, L.P.10% owner
Essex Woodlands IX, LLC10% owner
|
SaleCommon Stock, $0.001 par value | 7,017 | $11.02 | $77,337.16 |
DisclosureSEC source: 0000899243-23-018636 · doc4.xml · nonDerivative · entry 4 EW Healthcare Partners, L.P. · CIK 0001612343 · 10% owner · See footnotes 1 and 6 EW Healthcare Partners-A, L.P. · CIK 0001736240 · 10% owner · See footnotes 1 and 6 Essex Woodlands Fund IX-GP, L.P. · CIK 0001652285 · 10% owner Essex Woodlands IX, LLC · CIK 0001652286 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 3,510,921 F5 · price: Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date within a one dollar range. Actual prices ranged from $10.84 to $11.23. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · ownership.nature: The share totals shown above are the aggregate amounts of shares of Common Stock sold by EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A") on the dates set forth above. EWHP sold 58,616 shares and 75,457 shares of the amounts shown above on August 30, 2023 and August 31, 2023, respectively, and EWHP-A sold 2,360 shares and 3,038 shares of the amounts shown above on August 30, 2023 and August 31, 2023, respectively. EWHP now holds a total of 3,375,147 shares of Common Stock of the Issuer and EWHP-A now holds a total of 135,774 shares of Common Stock of the Issuer. F6 · ownership.nature: Essex Woodlands Fund IX-GP, L.P. (the "EW Fund IX GP"), is the general partner of each of EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A" and together with EWHP, the "EWHP Funds"). Essex Woodlands IX, LLC (the "General Partner") is the general partner of EW Fund IX GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EWHP Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Scott Barry, Ron Eastman, Petri Vainio and Steve Wiggins (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Fund IX GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| August 31, 2023 Filed Sep 1, 2023 16:51 UTC |
EW Healthcare Partners, L.P.10% owner · See footnotes 1 and 6
EW Healthcare Partners-A, L.P.10% owner · See footnotes 1 and 6
Essex Woodlands Fund IX-GP, L.P.10% owner
Essex Woodlands IX, LLC10% owner
|
SaleCommon Stock, $0.001 par value | 71,478 | $10.17 | $726,723.97 |
DisclosureSEC source: 0000899243-23-018636 · doc4.xml · nonDerivative · entry 3 EW Healthcare Partners, L.P. · CIK 0001612343 · 10% owner · See footnotes 1 and 6 EW Healthcare Partners-A, L.P. · CIK 0001736240 · 10% owner · See footnotes 1 and 6 Essex Woodlands Fund IX-GP, L.P. · CIK 0001652285 · 10% owner Essex Woodlands IX, LLC · CIK 0001652286 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 3,517,938 F4 · price: Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date within a one dollar range. Actual prices ranged from $9.83 to $10.76. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · ownership.nature: The share totals shown above are the aggregate amounts of shares of Common Stock sold by EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A") on the dates set forth above. EWHP sold 58,616 shares and 75,457 shares of the amounts shown above on August 30, 2023 and August 31, 2023, respectively, and EWHP-A sold 2,360 shares and 3,038 shares of the amounts shown above on August 30, 2023 and August 31, 2023, respectively. EWHP now holds a total of 3,375,147 shares of Common Stock of the Issuer and EWHP-A now holds a total of 135,774 shares of Common Stock of the Issuer. F6 · ownership.nature: Essex Woodlands Fund IX-GP, L.P. (the "EW Fund IX GP"), is the general partner of each of EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A" and together with EWHP, the "EWHP Funds"). Essex Woodlands IX, LLC (the "General Partner") is the general partner of EW Fund IX GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EWHP Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Scott Barry, Ron Eastman, Petri Vainio and Steve Wiggins (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Fund IX GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| August 30, 2023 Filed Sep 1, 2023 16:51 UTC |
EW Healthcare Partners, L.P.10% owner · See footnotes 1 and 6
EW Healthcare Partners-A, L.P.10% owner · See footnotes 1 and 6
Essex Woodlands Fund IX-GP, L.P.10% owner
Essex Woodlands IX, LLC10% owner
|
SaleCommon Stock, $0.001 par value | 327 | $11.36 | $3,714.56 |
DisclosureSEC source: 0000899243-23-018636 · doc4.xml · nonDerivative · entry 2 EW Healthcare Partners, L.P. · CIK 0001612343 · 10% owner · See footnotes 1 and 6 EW Healthcare Partners-A, L.P. · CIK 0001736240 · 10% owner · See footnotes 1 and 6 Essex Woodlands Fund IX-GP, L.P. · CIK 0001652285 · 10% owner Essex Woodlands IX, LLC · CIK 0001652286 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 3,589,416 F3 · price: Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date within a one dollar range. Actual prices ranged from $11.35 to $11.37. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · ownership.nature: The share totals shown above are the aggregate amounts of shares of Common Stock sold by EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A") on the dates set forth above. EWHP sold 58,616 shares and 75,457 shares of the amounts shown above on August 30, 2023 and August 31, 2023, respectively, and EWHP-A sold 2,360 shares and 3,038 shares of the amounts shown above on August 30, 2023 and August 31, 2023, respectively. EWHP now holds a total of 3,375,147 shares of Common Stock of the Issuer and EWHP-A now holds a total of 135,774 shares of Common Stock of the Issuer. F6 · ownership.nature: Essex Woodlands Fund IX-GP, L.P. (the "EW Fund IX GP"), is the general partner of each of EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A" and together with EWHP, the "EWHP Funds"). Essex Woodlands IX, LLC (the "General Partner") is the general partner of EW Fund IX GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EWHP Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Scott Barry, Ron Eastman, Petri Vainio and Steve Wiggins (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Fund IX GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| August 30, 2023 Filed Sep 1, 2023 16:51 UTC |
EW Healthcare Partners, L.P.10% owner · See footnotes 1 and 6
EW Healthcare Partners-A, L.P.10% owner · See footnotes 1 and 6
Essex Woodlands Fund IX-GP, L.P.10% owner
Essex Woodlands IX, LLC10% owner
|
SaleCommon Stock, $0.001 par value | 60,649 | $10.92 | $662,432.64 |
DisclosureSEC source: 0000899243-23-018636 · doc4.xml · nonDerivative · entry 1 EW Healthcare Partners, L.P. · CIK 0001612343 · 10% owner · See footnotes 1 and 6 EW Healthcare Partners-A, L.P. · CIK 0001736240 · 10% owner · See footnotes 1 and 6 Essex Woodlands Fund IX-GP, L.P. · CIK 0001652285 · 10% owner Essex Woodlands IX, LLC · CIK 0001652286 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 3,589,743 F2 · price: Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date within a one dollar range. Actual prices ranged from $10.32 to $11.29. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · ownership.nature: The share totals shown above are the aggregate amounts of shares of Common Stock sold by EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A") on the dates set forth above. EWHP sold 58,616 shares and 75,457 shares of the amounts shown above on August 30, 2023 and August 31, 2023, respectively, and EWHP-A sold 2,360 shares and 3,038 shares of the amounts shown above on August 30, 2023 and August 31, 2023, respectively. EWHP now holds a total of 3,375,147 shares of Common Stock of the Issuer and EWHP-A now holds a total of 135,774 shares of Common Stock of the Issuer. F6 · ownership.nature: Essex Woodlands Fund IX-GP, L.P. (the "EW Fund IX GP"), is the general partner of each of EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A" and together with EWHP, the "EWHP Funds"). Essex Woodlands IX, LLC (the "General Partner") is the general partner of EW Fund IX GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EWHP Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Scott Barry, Ron Eastman, Petri Vainio and Steve Wiggins (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Fund IX GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| August 29, 2023 Filed Aug 30, 2023 17:46 UTC |
EW Healthcare Partners, L.P.10% owner · See footnotes 1 and 4
EW Healthcare Partners-A, L.P.10% owner · See footnotes 1 and 4
Essex Woodlands Fund IX-GP, L.P.10% owner
Essex Woodlands IX, LLC10% owner
|
SaleCommon Stock, $0.001 par value | 565 | $11.56 | $6,531.40 |
DisclosureSEC source: 0000899243-23-018610 · doc4.xml · nonDerivative · entry 3 EW Healthcare Partners, L.P. · CIK 0001612343 · 10% owner · See footnotes 1 and 4 EW Healthcare Partners-A, L.P. · CIK 0001736240 · 10% owner · See footnotes 1 and 4 Essex Woodlands Fund IX-GP, L.P. · CIK 0001652285 · 10% owner Essex Woodlands IX, LLC · CIK 0001652286 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,650,392 F1 · ownership.nature: The share totals shown above are the aggregate amounts of shares of Common Stock sold by EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A") on the dates set forth above. EWHP sold 58,503 shares and 84,454 shares of the amounts shown above on August 28, 2023 and August 29, 2023, respectively, and EWHP-A sold 2,355 shares and 3,400 shares of the amounts shown above on August 28, 2023 and August 29, 2023, respectively. EWHP now holds a total of 3,509,220 shares of Common Stock of the Issuer and EWHP-A now holds a total of 141,172 shares of Common Stock of the Issuer. F4 · ownership.nature: Essex Woodlands Fund IX-GP, L.P. (the "EW Fund IX GP"), is the general partner of each of EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A" and together with EWHP, the "EWHP Funds"). Essex Woodlands IX, LLC (the "General Partner") is the general partner of EW Fund IX GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Scott Barry, Ron Eastman, Petri Vainio and Steve Wiggins (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| August 29, 2023 Filed Aug 30, 2023 17:46 UTC |
EW Healthcare Partners, L.P.10% owner · See footnotes 1 and 4
EW Healthcare Partners-A, L.P.10% owner · See footnotes 1 and 4
Essex Woodlands Fund IX-GP, L.P.10% owner
Essex Woodlands IX, LLC10% owner
|
SaleCommon Stock, $0.001 par value | 87,289 | $10.74 | $937,693.35 |
DisclosureSEC source: 0000899243-23-018610 · doc4.xml · nonDerivative · entry 2 EW Healthcare Partners, L.P. · CIK 0001612343 · 10% owner · See footnotes 1 and 4 EW Healthcare Partners-A, L.P. · CIK 0001736240 · 10% owner · See footnotes 1 and 4 Essex Woodlands Fund IX-GP, L.P. · CIK 0001652285 · 10% owner Essex Woodlands IX, LLC · CIK 0001652286 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,650,957 F3 · price: Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date within a one dollar range. Actual prices ranged from $10.30 to $11.29. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · ownership.nature: The share totals shown above are the aggregate amounts of shares of Common Stock sold by EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A") on the dates set forth above. EWHP sold 58,503 shares and 84,454 shares of the amounts shown above on August 28, 2023 and August 29, 2023, respectively, and EWHP-A sold 2,355 shares and 3,400 shares of the amounts shown above on August 28, 2023 and August 29, 2023, respectively. EWHP now holds a total of 3,509,220 shares of Common Stock of the Issuer and EWHP-A now holds a total of 141,172 shares of Common Stock of the Issuer. F4 · ownership.nature: Essex Woodlands Fund IX-GP, L.P. (the "EW Fund IX GP"), is the general partner of each of EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A" and together with EWHP, the "EWHP Funds"). Essex Woodlands IX, LLC (the "General Partner") is the general partner of EW Fund IX GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Scott Barry, Ron Eastman, Petri Vainio and Steve Wiggins (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| August 28, 2023 Filed Aug 30, 2023 17:46 UTC |
EW Healthcare Partners, L.P.10% owner · See footnotes 1 and 4
EW Healthcare Partners-A, L.P.10% owner · See footnotes 1 and 4
Essex Woodlands Fund IX-GP, L.P.10% owner
Essex Woodlands IX, LLC10% owner
|
SaleCommon Stock, $0.001 par value | 60,858 | $11.71 | $712,653.27 |
DisclosureSEC source: 0000899243-23-018610 · doc4.xml · nonDerivative · entry 1 EW Healthcare Partners, L.P. · CIK 0001612343 · 10% owner · See footnotes 1 and 4 EW Healthcare Partners-A, L.P. · CIK 0001736240 · 10% owner · See footnotes 1 and 4 Essex Woodlands Fund IX-GP, L.P. · CIK 0001652285 · 10% owner Essex Woodlands IX, LLC · CIK 0001652286 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,738,246 F2 · price: Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date within a one dollar range. Actual prices ranged from $11.28 to $12.00. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · ownership.nature: The share totals shown above are the aggregate amounts of shares of Common Stock sold by EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A") on the dates set forth above. EWHP sold 58,503 shares and 84,454 shares of the amounts shown above on August 28, 2023 and August 29, 2023, respectively, and EWHP-A sold 2,355 shares and 3,400 shares of the amounts shown above on August 28, 2023 and August 29, 2023, respectively. EWHP now holds a total of 3,509,220 shares of Common Stock of the Issuer and EWHP-A now holds a total of 141,172 shares of Common Stock of the Issuer. F4 · ownership.nature: Essex Woodlands Fund IX-GP, L.P. (the "EW Fund IX GP"), is the general partner of each of EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A" and together with EWHP, the "EWHP Funds"). Essex Woodlands IX, LLC (the "General Partner") is the general partner of EW Fund IX GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Scott Barry, Ron Eastman, Petri Vainio and Steve Wiggins (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| August 25, 2023 Filed Aug 28, 2023 18:32 UTC |
EW Healthcare Partners, L.P.10% owner · See footnotes 1 and 2
EW Healthcare Partners-A, L.P.10% owner · See footnotes 1 and 2
Essex Woodlands Fund IX-GP, L.P.10% owner
Essex Woodlands IX, LLC10% owner
|
SaleCommon Stock, $0.001 par value | 54,656 | $11.19 | $611,349.22 |
DisclosureSEC source: 0000950170-23-044843 · ownership.xml · nonDerivative · entry 3 EW Healthcare Partners, L.P. · CIK 0001612343 · 10% owner · See footnotes 1 and 2 EW Healthcare Partners-A, L.P. · CIK 0001736240 · 10% owner · See footnotes 1 and 2 Essex Woodlands Fund IX-GP, L.P. · CIK 0001652285 · 10% owner Essex Woodlands IX, LLC · CIK 0001652286 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,799,104 F1 · ownership.nature: The share totals shown above are the aggregate amounts of shares of Common Stock sold by EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A") on the dates set forth above. EWHP sold 133,890 shares and 81,380 shares of the amounts shown above on August 24, 2023 and August 25, 2023, respectively, and EWHP-A sold 5,390 shares and 3,276 shares of the amounts shown above on August 24, 2023 and August 25, 2023, respectively. EWHP now holds a total of 3,652,177 shares of Common Stock of the Issuer and EWHP-A now holds a total of 146,927 shares of Common Stock of the Issuer. F2 · ownership.nature: Essex Woodlands Fund IX-GP, L.P. (the "EW Fund IX GP"), is the general partner of each of EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A" and together with EWHP, the "EWHP Funds"). Essex Woodlands IX, LLC (the "General Partner") is the general partner of EW Fund IX GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Scott Barry, Ron Eastman, Petri Vainio and Steve Wiggins (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| August 25, 2023 Filed Aug 28, 2023 18:32 UTC |
EW Healthcare Partners, L.P.10% owner · See footnotes 1 and 2
EW Healthcare Partners-A, L.P.10% owner · See footnotes 1 and 2
Essex Woodlands Fund IX-GP, L.P.10% owner
Essex Woodlands IX, LLC10% owner
|
SaleCommon Stock, $0.001 par value | 30,000 | $10.67 | $320,130.00 |
DisclosureSEC source: 0000950170-23-044843 · ownership.xml · nonDerivative · entry 2 EW Healthcare Partners, L.P. · CIK 0001612343 · 10% owner · See footnotes 1 and 2 EW Healthcare Partners-A, L.P. · CIK 0001736240 · 10% owner · See footnotes 1 and 2 Essex Woodlands Fund IX-GP, L.P. · CIK 0001652285 · 10% owner Essex Woodlands IX, LLC · CIK 0001652286 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,853,760 F1 · ownership.nature: The share totals shown above are the aggregate amounts of shares of Common Stock sold by EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A") on the dates set forth above. EWHP sold 133,890 shares and 81,380 shares of the amounts shown above on August 24, 2023 and August 25, 2023, respectively, and EWHP-A sold 5,390 shares and 3,276 shares of the amounts shown above on August 24, 2023 and August 25, 2023, respectively. EWHP now holds a total of 3,652,177 shares of Common Stock of the Issuer and EWHP-A now holds a total of 146,927 shares of Common Stock of the Issuer. F2 · ownership.nature: Essex Woodlands Fund IX-GP, L.P. (the "EW Fund IX GP"), is the general partner of each of EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A" and together with EWHP, the "EWHP Funds"). Essex Woodlands IX, LLC (the "General Partner") is the general partner of EW Fund IX GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Scott Barry, Ron Eastman, Petri Vainio and Steve Wiggins (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| August 25, 2023 Filed Aug 30, 2023 17:32 UTC Amendment |
EW Healthcare Partners, L.P.10% owner · See footnotes 1 and 6
EW Healthcare Partners-A, L.P.10% owner · See footnotes 1 and 6
Essex Woodlands Fund IX-GP, L.P.10% owner
Essex Woodlands IX, LLC10% owner
|
SaleCommon Stock, $0.001 par value | 11,731 | $10.45 | $122,588.95 |
DisclosureSEC source: 0000899243-23-018606 · doc4a.xml · nonDerivative · entry 4 EW Healthcare Partners, L.P. · CIK 0001612343 · 10% owner · See footnotes 1 and 6 EW Healthcare Partners-A, L.P. · CIK 0001736240 · 10% owner · See footnotes 1 and 6 Essex Woodlands Fund IX-GP, L.P. · CIK 0001652285 · 10% owner Essex Woodlands IX, LLC · CIK 0001652286 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 3,799,104 F5 · price: Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date within a one dollar range. Actual prices ranged from $10.36 to $10.50. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F7 · price: This Amended Form 4 is being filed to correct an administrative error in reporting the weighted average prices at which shares were sold on August 24, 2023 and August 25, 2023 from that reported in the original Form 4 to the prices shown in this Amended Form 4. F1 · ownership.nature: The share totals shown above are the aggregate amounts of shares of Common Stock sold by EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A") on the dates set forth above. EWHP sold 133,890 shares and 81,380 shares of the amounts shown above on August 24, 2023 and August 25, 2023, respectively, and EWHP-A sold 5,390 shares and 3,276 shares of the amounts shown above on August 24, 2023 and August 25, 2023, respectively. EWHP now holds a total of 3,652,177 shares of Common Stock of the Issuer and EWHP-A now holds a total of 146,927 shares of Common Stock of the Issuer. F6 · ownership.nature: Essex Woodlands Fund IX-GP, L.P. (the "EW Fund IX GP"), is the general partner of each of EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A" and together with EWHP, the "EWHP Funds"). Essex Woodlands IX, LLC (the "General Partner") is the general partner of EW Fund IX GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Scott Barry, Ron Eastman, Petri Vainio and Steve Wiggins (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| August 25, 2023 Filed Aug 30, 2023 17:32 UTC Amendment |
EW Healthcare Partners, L.P.10% owner · See footnotes 1 and 6
EW Healthcare Partners-A, L.P.10% owner · See footnotes 1 and 6
Essex Woodlands Fund IX-GP, L.P.10% owner
Essex Woodlands IX, LLC10% owner
|
SaleCommon Stock, $0.001 par value | 72,925 | $11.09 | $808,738.25 |
DisclosureSEC source: 0000899243-23-018606 · doc4a.xml · nonDerivative · entry 3 EW Healthcare Partners, L.P. · CIK 0001612343 · 10% owner · See footnotes 1 and 6 EW Healthcare Partners-A, L.P. · CIK 0001736240 · 10% owner · See footnotes 1 and 6 Essex Woodlands Fund IX-GP, L.P. · CIK 0001652285 · 10% owner Essex Woodlands IX, LLC · CIK 0001652286 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 3,810,835 F4 · price: Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date within a one dollar range. Actual prices ranged from $10.5001 to $11.50. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F7 · price: This Amended Form 4 is being filed to correct an administrative error in reporting the weighted average prices at which shares were sold on August 24, 2023 and August 25, 2023 from that reported in the original Form 4 to the prices shown in this Amended Form 4. F1 · ownership.nature: The share totals shown above are the aggregate amounts of shares of Common Stock sold by EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A") on the dates set forth above. EWHP sold 133,890 shares and 81,380 shares of the amounts shown above on August 24, 2023 and August 25, 2023, respectively, and EWHP-A sold 5,390 shares and 3,276 shares of the amounts shown above on August 24, 2023 and August 25, 2023, respectively. EWHP now holds a total of 3,652,177 shares of Common Stock of the Issuer and EWHP-A now holds a total of 146,927 shares of Common Stock of the Issuer. F6 · ownership.nature: Essex Woodlands Fund IX-GP, L.P. (the "EW Fund IX GP"), is the general partner of each of EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A" and together with EWHP, the "EWHP Funds"). Essex Woodlands IX, LLC (the "General Partner") is the general partner of EW Fund IX GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Scott Barry, Ron Eastman, Petri Vainio and Steve Wiggins (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| August 24, 2023 Filed Aug 28, 2023 18:32 UTC |
EW Healthcare Partners, L.P.10% owner · See footnotes 1 and 2
EW Healthcare Partners-A, L.P.10% owner · See footnotes 1 and 2
Essex Woodlands Fund IX-GP, L.P.10% owner
Essex Woodlands IX, LLC10% owner
|
SaleCommon Stock, $0.001 par value | 139,280 | $14.62 | $2,036,092.54 |
DisclosureSEC source: 0000950170-23-044843 · ownership.xml · nonDerivative · entry 1 EW Healthcare Partners, L.P. · CIK 0001612343 · 10% owner · See footnotes 1 and 2 EW Healthcare Partners-A, L.P. · CIK 0001736240 · 10% owner · See footnotes 1 and 2 Essex Woodlands Fund IX-GP, L.P. · CIK 0001652285 · 10% owner Essex Woodlands IX, LLC · CIK 0001652286 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 3,883,760 F1 · ownership.nature: The share totals shown above are the aggregate amounts of shares of Common Stock sold by EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A") on the dates set forth above. EWHP sold 133,890 shares and 81,380 shares of the amounts shown above on August 24, 2023 and August 25, 2023, respectively, and EWHP-A sold 5,390 shares and 3,276 shares of the amounts shown above on August 24, 2023 and August 25, 2023, respectively. EWHP now holds a total of 3,652,177 shares of Common Stock of the Issuer and EWHP-A now holds a total of 146,927 shares of Common Stock of the Issuer. F2 · ownership.nature: Essex Woodlands Fund IX-GP, L.P. (the "EW Fund IX GP"), is the general partner of each of EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A" and together with EWHP, the "EWHP Funds"). Essex Woodlands IX, LLC (the "General Partner") is the general partner of EW Fund IX GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Scott Barry, Ron Eastman, Petri Vainio and Steve Wiggins (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| August 24, 2023 Filed Aug 30, 2023 17:32 UTC Amendment |
EW Healthcare Partners, L.P.10% owner · See footnotes 1 and 6
EW Healthcare Partners-A, L.P.10% owner · See footnotes 1 and 6
Essex Woodlands Fund IX-GP, L.P.10% owner
Essex Woodlands IX, LLC10% owner
|
SaleCommon Stock, $0.001 par value | 52,180 | $10.56 | $551,020.80 |
DisclosureSEC source: 0000899243-23-018606 · doc4a.xml · nonDerivative · entry 2 EW Healthcare Partners, L.P. · CIK 0001612343 · 10% owner · See footnotes 1 and 6 EW Healthcare Partners-A, L.P. · CIK 0001736240 · 10% owner · See footnotes 1 and 6 Essex Woodlands Fund IX-GP, L.P. · CIK 0001652285 · 10% owner Essex Woodlands IX, LLC · CIK 0001652286 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 3,883,760 F3 · price: Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date within a one dollar range. Actual prices ranged from $10.11 to $11.04. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F7 · price: This Amended Form 4 is being filed to correct an administrative error in reporting the weighted average prices at which shares were sold on August 24, 2023 and August 25, 2023 from that reported in the original Form 4 to the prices shown in this Amended Form 4. F1 · ownership.nature: The share totals shown above are the aggregate amounts of shares of Common Stock sold by EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A") on the dates set forth above. EWHP sold 133,890 shares and 81,380 shares of the amounts shown above on August 24, 2023 and August 25, 2023, respectively, and EWHP-A sold 5,390 shares and 3,276 shares of the amounts shown above on August 24, 2023 and August 25, 2023, respectively. EWHP now holds a total of 3,652,177 shares of Common Stock of the Issuer and EWHP-A now holds a total of 146,927 shares of Common Stock of the Issuer. F6 · ownership.nature: Essex Woodlands Fund IX-GP, L.P. (the "EW Fund IX GP"), is the general partner of each of EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A" and together with EWHP, the "EWHP Funds"). Essex Woodlands IX, LLC (the "General Partner") is the general partner of EW Fund IX GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Scott Barry, Ron Eastman, Petri Vainio and Steve Wiggins (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| August 24, 2023 Filed Aug 30, 2023 17:32 UTC Amendment |
EW Healthcare Partners, L.P.10% owner · See footnotes 1 and 6
EW Healthcare Partners-A, L.P.10% owner · See footnotes 1 and 6
Essex Woodlands Fund IX-GP, L.P.10% owner
Essex Woodlands IX, LLC10% owner
|
SaleCommon Stock, $0.001 par value | 87,100 | $11.54 | $1,005,134.00 |
DisclosureSEC source: 0000899243-23-018606 · doc4a.xml · nonDerivative · entry 1 EW Healthcare Partners, L.P. · CIK 0001612343 · 10% owner · See footnotes 1 and 6 EW Healthcare Partners-A, L.P. · CIK 0001736240 · 10% owner · See footnotes 1 and 6 Essex Woodlands Fund IX-GP, L.P. · CIK 0001652285 · 10% owner Essex Woodlands IX, LLC · CIK 0001652286 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 3,935,940 F2 · price: Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date within a one dollar range. Actual prices ranged from $11.05 to $12.04. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F7 · price: This Amended Form 4 is being filed to correct an administrative error in reporting the weighted average prices at which shares were sold on August 24, 2023 and August 25, 2023 from that reported in the original Form 4 to the prices shown in this Amended Form 4. F1 · ownership.nature: The share totals shown above are the aggregate amounts of shares of Common Stock sold by EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A") on the dates set forth above. EWHP sold 133,890 shares and 81,380 shares of the amounts shown above on August 24, 2023 and August 25, 2023, respectively, and EWHP-A sold 5,390 shares and 3,276 shares of the amounts shown above on August 24, 2023 and August 25, 2023, respectively. EWHP now holds a total of 3,652,177 shares of Common Stock of the Issuer and EWHP-A now holds a total of 146,927 shares of Common Stock of the Issuer. F6 · ownership.nature: Essex Woodlands Fund IX-GP, L.P. (the "EW Fund IX GP"), is the general partner of each of EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A" and together with EWHP, the "EWHP Funds"). Essex Woodlands IX, LLC (the "General Partner") is the general partner of EW Fund IX GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Scott Barry, Ron Eastman, Petri Vainio and Steve Wiggins (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| August 23, 2023 Filed Aug 24, 2023 17:30 UTC |
EW Healthcare Partners, L.P.10% owner · See footnotes 1 and 2
EW Healthcare Partners-A, L.P.10% owner · See footnotes 1 and 2
Essex Woodlands Fund IX-GP, L.P.10% owner
Essex Woodlands IX, LLC10% owner
|
SaleCommon Stock, $0.001 par value | 121,103 | $13.05 | $1,580,914.89 |
DisclosureSEC source: 0000899243-23-018380 · doc4.xml · nonDerivative · entry 2 EW Healthcare Partners, L.P. · CIK 0001612343 · 10% owner · See footnotes 1 and 2 EW Healthcare Partners-A, L.P. · CIK 0001736240 · 10% owner · See footnotes 1 and 2 Essex Woodlands Fund IX-GP, L.P. · CIK 0001652285 · 10% owner Essex Woodlands IX, LLC · CIK 0001652286 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 4,023,040 F1 · ownership.nature: The share totals shown above are the aggregate amounts of shares of Common Stock sold by EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A") on the dates set forth above. EWHP sold 44,968 shares and 116,416 shares of the amounts shown above on August 22, 2023 and August 23, 2023, respectively, and EWHP-A sold 1,810 shares and 4,687 shares of the amounts shown above on August 22, 2023 and August 23, 2023, respectively. EWHP now holds a total of 3,867,447 shares of Common Stock of the Issuer and EWHP-A now holds a total of 155,593 shares of Common Stock of the Issuer. F2 · ownership.nature: Essex Woodlands Fund IX-GP, L.P. (the "EW Fund IX GP"), is the general partner of each of EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A" and together with EWHP, the "EWHP Funds"). Essex Woodlands IX, LLC (the "General Partner") is the general partner of EW Fund IX GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EWHP Funds (the "Shares"). The managers of the General Partner are Martin P. Sutter, Scott Barry, Ron Eastman, Petri Vainio and Scott Wiggins (collectively, the "Managers") and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| August 22, 2023 Filed Aug 24, 2023 17:30 UTC |
EW Healthcare Partners, L.P.10% owner · See footnotes 1 and 2
EW Healthcare Partners-A, L.P.10% owner · See footnotes 1 and 2
Essex Woodlands Fund IX-GP, L.P.10% owner
Essex Woodlands IX, LLC10% owner
|
SaleCommon Stock, $0.001 par value | 46,778 | $14.62 | $683,833.55 |
DisclosureSEC source: 0000899243-23-018380 · doc4.xml · nonDerivative · entry 1 EW Healthcare Partners, L.P. · CIK 0001612343 · 10% owner · See footnotes 1 and 2 EW Healthcare Partners-A, L.P. · CIK 0001736240 · 10% owner · See footnotes 1 and 2 Essex Woodlands Fund IX-GP, L.P. · CIK 0001652285 · 10% owner Essex Woodlands IX, LLC · CIK 0001652286 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 4,144,143 F1 · ownership.nature: The share totals shown above are the aggregate amounts of shares of Common Stock sold by EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A") on the dates set forth above. EWHP sold 44,968 shares and 116,416 shares of the amounts shown above on August 22, 2023 and August 23, 2023, respectively, and EWHP-A sold 1,810 shares and 4,687 shares of the amounts shown above on August 22, 2023 and August 23, 2023, respectively. EWHP now holds a total of 3,867,447 shares of Common Stock of the Issuer and EWHP-A now holds a total of 155,593 shares of Common Stock of the Issuer. F2 · ownership.nature: Essex Woodlands Fund IX-GP, L.P. (the "EW Fund IX GP"), is the general partner of each of EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A" and together with EWHP, the "EWHP Funds"). Essex Woodlands IX, LLC (the "General Partner") is the general partner of EW Fund IX GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EWHP Funds (the "Shares"). The managers of the General Partner are Martin P. Sutter, Scott Barry, Ron Eastman, Petri Vainio and Scott Wiggins (collectively, the "Managers") and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| July 11, 2023 Filed Jul 12, 2023 22:51 UTC |
Zaderej Karen L.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 2,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005879 · primarydocument.xml · derivative · entry 2 Zaderej Karen L. · CIK 0001530968 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 2,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning July 11, 2023. F1 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning July 11, 2023. Read SEC document |
| July 11, 2023 Filed Jul 12, 2023 22:51 UTC |
Zaderej Karen L.Director
|
Exercise / conversionCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005879 · primarydocument.xml · nonDerivative · entry 1 Zaderej Karen L. · CIK 0001530968 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 10, 2023 Filed Jul 12, 2023 22:52 UTC |
Lurker NancyDirector · Executive Vice Chair
|
GrantStock Option (Right to Buy) · Derivative | 66,666 | $0.00 Strike: $9.11 | $0.00 |
DisclosureSEC source: 0001562180-23-005880 · primarydocument.xml · derivative · entry 2 Lurker Nancy · CIK 0001450485 · Director · Executive Vice Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,666 Underlying: Common Stock · 66,666 shares Expires 2033-07-10 F2 · derivative.exercise_date: The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months Read SEC document |
| July 10, 2023 Filed Jul 12, 2023 22:52 UTC |
Lurker NancyDirector · Executive Vice Chair
|
GrantRestricted Stock Units · Derivative | 33,334 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005880 · primarydocument.xml · derivative · entry 1 Lurker Nancy · CIK 0001450485 · Director · Executive Vice Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,334 Underlying: Common Stock · 33,334 shares Expires not disclosed F1 · derivative.exercise_date: The restricted stock units will vest in three ratable annual installments beginning July 10, 2024. F1 · derivative.expiration_date: The restricted stock units will vest in three ratable annual installments beginning July 10, 2024. Read SEC document |
| July 10, 2023 Filed Jul 12, 2023 22:53 UTC |
Duker Jay S.Director · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $9.11 | $0.00 |
DisclosureSEC source: 0001562180-23-005881 · primarydocument.xml · derivative · entry 2 Duker Jay S. · CIK 0001630864 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2033-07-10 F2 · derivative.exercise_date: The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months Read SEC document |
| July 10, 2023 Filed Jul 12, 2023 22:53 UTC |
Duker Jay S.Director · President and CEO
|
GrantRestricted Stock Units · Derivative | 50,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005881 · primarydocument.xml · derivative · entry 1 Duker Jay S. · CIK 0001630864 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F1 · derivative.exercise_date: The restricted stock units will vest in three ratable annual installments beginning July 10, 2024. F1 · derivative.expiration_date: The restricted stock units will vest in three ratable annual installments beginning July 10, 2024. Read SEC document |
| June 23, 2023 Filed Jun 26, 2023 21:10 UTC |
ADAMIS ANTHONY PDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005502 · primarydocument.xml · derivative · entry 2 ADAMIS ANTHONY P · CIK 0001277479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 2,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units will vest in three equal annual installments beginning June 23, 2023. F1 · derivative.expiration_date: The restricted stock units will vest in three equal annual installments beginning June 23, 2023. Read SEC document |
| June 23, 2023 Filed Jun 26, 2023 21:10 UTC |
ADAMIS ANTHONY PDirector
|
Exercise / conversionCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005502 · primarydocument.xml · nonDerivative · entry 1 ADAMIS ANTHONY P · CIK 0001277479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 09:19 UTC |
ANDO GORANDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,500 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001562180-23-005448 · primarydocument.xml · derivative · entry 2 ANDO GORAN · CIK 0001110748 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,500 Underlying: Common Stock · 13,500 shares Expires 2033-06-19 Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 09:19 UTC |
ANDO GORANDirector
|
GrantStock Option (Right to Buy) · Derivative | 27,100 | $0.00 Strike: $3.26 | $0.00 |
DisclosureSEC source: 0001562180-23-005448 · primarydocument.xml · derivative · entry 1 ANDO GORAN · CIK 0001110748 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,100 Underlying: Common Stock · 27,100 shares Expires 2033-06-19 Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 09:16 UTC |
Jones David ScottSVP & Chief Commercial Officer
|
GrantRestricted Stock Units · Derivative | 45,855 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005444 · primarydocument.xml · derivative · entry 1 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,855 Underlying: Common Stock · 45,855 shares Expires not disclosed F1 · derivative.exercise_date: The restricted stock units will vest in three ratable annual installments beginning January 6, 2024. F1 · derivative.expiration_date: The restricted stock units will vest in three ratable annual installments beginning January 6, 2024. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 09:21 UTC |
Landis John B.Director
|
GrantStock Option (Right to Buy) · Derivative | 13,000 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001562180-23-005450 · primarydocument.xml · derivative · entry 2 Landis John B. · CIK 0001477283 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Stock · 13,000 shares Expires 2033-06-19 Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 09:21 UTC |
Landis John B.Director
|
GrantStock Option (Right to Buy) · Derivative | 26,100 | $0.00 Strike: $3.26 | $0.00 |
DisclosureSEC source: 0001562180-23-005450 · primarydocument.xml · derivative · entry 1 Landis John B. · CIK 0001477283 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,100 Underlying: Common Stock · 26,100 shares Expires 2033-06-19 Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 13:14 UTC |
Lurker NancyDirector · CEO
|
GrantRestricted Stock Units · Derivative | 225,400 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005441 · primarydocument.xml · derivative · entry 1 Lurker Nancy · CIK 0001450485 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,400 Underlying: Common Stock · 225,400 shares Expires not disclosed F1 · derivative.exercise_date: The restricted stock units will vest in three ratable annual installments beginning January 6, 2024. F1 · derivative.expiration_date: The restricted stock units will vest in three ratable annual installments beginning January 6, 2024. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 13:15 UTC |
Elston GeorgeChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 45,855 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005442 · primarydocument.xml · derivative · entry 1 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,855 Underlying: Common Stock · 45,855 shares Expires not disclosed F1 · derivative.exercise_date: The restricted stock units will vest in three ratable annual installments beginning January 6, 2024. F1 · derivative.expiration_date: The restricted stock units will vest in three ratable annual installments beginning January 6, 2024. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 09:19 UTC |
DICICCO WENDY FDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,000 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001562180-23-005449 · primarydocument.xml · derivative · entry 2 DICICCO WENDY F · CIK 0001225165 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Stock · 13,000 shares Expires 2033-06-19 Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 09:19 UTC |
DICICCO WENDY FDirector
|
GrantStock Option (Right to Buy) · Derivative | 26,100 | $0.00 Strike: $3.26 | $0.00 |
DisclosureSEC source: 0001562180-23-005449 · primarydocument.xml · derivative · entry 1 DICICCO WENDY F · CIK 0001225165 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,100 Underlying: Common Stock · 26,100 shares Expires 2033-06-19 Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 09:22 UTC |
GUYER DAVID RDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,000 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001562180-23-005451 · primarydocument.xml · derivative · entry 2 GUYER DAVID R · CIK 0001277476 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Stock · 13,000 shares Expires 2033-06-19 Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 09:22 UTC |
GUYER DAVID RDirector
|
GrantStock Option (Right to Buy) · Derivative | 26,100 | $0.00 Strike: $3.26 | $0.00 |
DisclosureSEC source: 0001562180-23-005451 · primarydocument.xml · derivative · entry 1 GUYER DAVID R · CIK 0001277476 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,100 Underlying: Common Stock · 26,100 shares Expires 2033-06-19 Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 13:18 UTC |
ADAMIS ANTHONY PDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,000 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001562180-23-005447 · primarydocument.xml · derivative · entry 2 ADAMIS ANTHONY P · CIK 0001277479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Stock · 13,000 shares Expires 2033-06-19 Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 13:18 UTC |
ADAMIS ANTHONY PDirector
|
GrantStock Option (Right to Buy) · Derivative | 26,100 | $0.00 Strike: $3.26 | $0.00 |
DisclosureSEC source: 0001562180-23-005447 · primarydocument.xml · derivative · entry 1 ADAMIS ANTHONY P · CIK 0001277479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,100 Underlying: Common Stock · 26,100 shares Expires 2033-06-19 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.